🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
134.00
-1.95 (-1.43%)
At close: Nov 18, 2026, 4:00 PM EST
133.76
-0.24 (-0.18%)
Pre-market: Nov 19, 2026, 8:22 AM EST

Axsome Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
313.86322.93315.35386.19200.8486.47
Cash & Short-Term Investments
313.86322.93315.35386.19200.8486.47
Cash Growth
-3.51%2.40%-18.34%92.29%132.26%-52.97%
Receivables
343.11224.4614294.8237.7-
Inventory
42.5827.9415.7315.144.32-
Prepaid Expenses
25.0813.6511.988.122.780.05
Total Current Assets
724.64588.99485.06504.26245.6486.52
Property, Plant & Equipment
19.2321.425.977.621.140.94
Goodwill
12.0412.0412.0412.0410.31-
Other Intangible Assets
35.7540.5246.8953.2959.66-
Other Long-Term Assets
35.1226.8418.5311.0314.720.32
Total Assets
826.77689.81568.5588.24331.4887.79

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
96.0865.547240.6838.6113.15
Accrued Expenses
326.2230.21145.6190.551.639.3
Short-Term Debt
7070----
Current Portion of Leases
6.222.983.261.270.430.62
Current Income Taxes Payable
-0.10.96---
Other Current Liabilities
11.2310.018.296.415.9-
Total Current Liabilities
509.72378.84230.1138.8596.5623.07
Long-Term Debt
118.07117.75180.71178.0794.2649.09
Long-Term Leases
29.9427.398.997.04--
Other Long-Term Liabilities
63.6177.5491.6873.331.1-
Total Liabilities
721.34601.51511.48397.26221.9272.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.0100
Additional Paid-In Capital
1,5401,3941,1801,027705.89424.83
Retained Earnings
-1,435-1,306-1,123-835.57-596.33-409.2
Shareholders' Equity
105.4388.357.02190.98109.5615.63
Total Liabilities & Equity
826.77689.81568.5588.24331.4887.79

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
224.23218.11192.96186.3794.6849.71
Net Cash (Debt)
89.63104.82122.4199.82106.1636.76
Net Cash Growth
-15.97%-14.36%-38.75%88.23%188.77%-72.51%
Net Cash Per Share
1.742.112.554.402.610.98
Filing Date Shares Outstanding
52.651.1548.7747.3743.5238.48
Total Common Shares Outstanding
52.5850.8848.6747.3543.537.82
Working Capital
214.92210.15254.96365.41149.0863.45
Book Value Per Share
2.011.741.174.032.520.41
Tangible Book Value
57.6435.73-1.92125.6539.5915.63
Tangible Book Value Per Share
1.100.70-0.042.650.910.41
SEC Filings: 10-K · 10-Q